C-Mer Medical Holdings Ltd
C-Mer Medical Holdings's GHG Emissions Data Preview
In 2023, C-Mer Medical Holdings completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy), and Scope 3 (indirect emissions across the value chain).
C-Mer Medical Holdings has also provided a category-level breakdown for 2 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 3 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
Insights into C-Mer Medical Holdings's Operational Emissions
In 2023, the total operational greenhouse gas (GHG) emissions of C-Mer Medical Holdings amounted to 4,374.47 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).
Compared to 2022, the total operational greenhouse gas (GHG) emissions of C-Mer Medical Holdings increased by 13.52%, suggesting that the company faced challenges in reducing its emissions from its core operations.
C-Mer Medical Holdings's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are C-Mer Medical Holdings's Scope 1 emissions?
In 2023, the total Scope 1 emissions of C-Mer Medical Holdings were 60.37 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Compared to the previous year (2022), C-Mer Medical Holdings's Scope 1 emissions decreased by 14.61%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.
What are C-Mer Medical Holdings's Scope 2 emissions?
In 2023, C-Mer Medical Holdings reported Scope 2 greenhouse gas (GHG) emissions of 4,314.1 tCOâ‚‚e without specifying the calculation method.
Has C-Mer Medical Holdings reduced its Scope 2 emissions over time?
Since 2020, C-Mer Medical Holdings's Scope 2 greenhouse gas (GHG) emissions (Unspecified Calculation Method) have increased by 182.84%, reflecting a rising long-term trend in Scope 2 emissions over time.
Compared to the previous year (2022), C-Mer Medical Holdings's Scope 2 emissions (Unspecified Calculation Method) rose by 14.04% in 2023, suggesting that the company faced challenges in reducing emissions from purchased electricity and energy
What methodology does C-Mer Medical Holdings use for Scope 2 reporting?
In 2023, C-Mer Medical Holdings reported its Scope 2 emissions using an unspecified methodology.
C-Mer Medical Holdings's Scope 2 Emissions Over Time
- Total Scope 2 (Unspecified Calculation Method)
Insights into C-Mer Medical Holdings's Value Chain Emissions
In 2023, C-Mer Medical Holdings reported 92.61 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.
The 2023 disclosure of C-Mer Medical Holdings includes a breakdown across 2 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2022, demonstrating consistent Scope 3 emissions reporting coverage year over year.
C-Mer Medical Holdings's Scope 3 Emissions Over Time
- Total Scope 3
- Year-over-Year Change
What are C-Mer Medical Holdings's Scope 3 emissions?
In 2023, C-Mer Medical Holdings reported total Scope 3 emissions of 92.61 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Approximately 100% of these emissions originated from upstream activities such as purchased goods and capital goods, while 0% came from downstream activities like product use, distribution, and end-of-life treatment.
Has C-Mer Medical Holdings reduced its Scope 3 emissions over time?
Since 2020, C-Mer Medical Holdings's Scope 3 emissions have increased by 125.27%, reflecting a rising long-term trend in Scope 3 emissions over time.
Compared to the previous year (2022), C-Mer Medical Holdings's Scope 3 emissions increased by 30.79%, suggesting that the company faced challenges in reducing emissions across its value chain.
What categories of Scope 3 emissions does C-Mer Medical Holdings disclose?
In 2023, C-Mer Medical Holdings reported emissions for 2 out of the 15 Scope 3 categories defined by the GHG Protocol.
The limited disclosure restricts visibility into specific emission sources across the company's value chain.
What are the main sources of C-Mer Medical Holdings's Scope 3 emissions?
In 2023, the largest contributors to C-Mer Medical Holdings's Scope 3 emissions were:
- Purchased Goods and Services (Cat. 1): 72.09 tCOâ‚‚e (77.84%)
- Business Travel (Cat. 6): 20.52 tCOâ‚‚e (22.16%)
C-Mer Medical Holdings's Scope 3 Emissions by Categories
Insights into C-Mer Medical Holdings's Total Carbon Footprint
In 2023, C-Mer Medical Holdings reported a total carbon footprint of 4,467.08 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 13.83% increase compared to 2022, suggesting a rise in emissions across its operations or value chain.
The largest contributor to C-Mer Medical Holdings's total carbon footprint was Scope 2 emissions, accounting for 96.58% of the company's total carbon footprint, followed by Scope 3 emissions at 2.07%.